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Abstract
Background: Various intramammary suspensions containing cloxacillin benzathine are registered for use in cattle
as antibiotics for intramammary use at drying off. To ensure antibacterial efficacy, the glandular tissue
concentration of an antimicrobial agent must be sufficient. Since the possibilities to measure concentrations in the
different areas of the glandular tissue in vivo are very limited, it was the aim of the present study to examine the
distribution of cloxacillin in vitro using the isolated perfused bovine udder.
Methods: Mammary glands taken at slaughter from healthy lactating cows were perfused in vitro with warmed
and gassed Tyrode solution. 600 mg cloxacillin benzathine were administered as Orbenin Extra Dry Cow by the
intramammary route to six front and rear quarters each. Samples of glandular tissue - at different distances from
and vertical to the teat right up to the udder base - were gathered from the treated quarters after 6 h. Perfusate
was also sampled before and hourly after treatment for 6 h. The cloxacillin content of the tissue samples and
perfusate samples was analysed by high performance liquid chromatography.
Results: The concentration of cloxacillin in the glandular tissue of front quarters measured 6 h after administration
tended to decrease with increasing vertical distance from the teat. The decrease pattern of the concentration was
not quite clear in rear quarters. A considerable variation in the tissue concentrations of cloxacillin was obvious,
which reflects in vivo conditions. The concentrations measured in the perfusate samples were below the limit of
quantification at all time points, indicating limited absorption of the antibiotic from the glandular tissue.
Conclusion: After intramammary administration of the dry off product containing cloxacillin benzathine
concentrations of more than 0.5 μg/g (MIC) were reached in all regions of the front and rear quarters.
Background
Various cloxacillin benzathine containing intramammary
suspensions are registered for use in cattle as antibiotics
for intramammary use at drying off. The drying off for-
mulations are recommended for routine use in cows at
drying off to treat existing intramammary infections and
to provide prolonged protection against new infections
during the dry period.
Cloxacillin is known as an effective agent against peni-
cillin-resistant and sensitive staphylococci (Staphylococ-
cus aureus), the most prevalent Gram positive pathogen
involved in persistent udder infections, which are
targeted by the drying off treatment. In a recent pan-
European survey, an MIC90 of 0.5 μg/mL against Sta-
phylococcus aureus (148 strains, isolated from cattle
with mastitis in different European countries) was
reported [15].
To ensure antibacterial efficacy, the glandular tissue
concentration of an antimicrobial agent must be suffi-
cient. For ethical and practical reasons, the local avail-
ability of active compounds in vivo is usually only
assessed by sampling milk and blood [1,10,11]. Since the
concentrations in the different areas of the glandular tis-
sue cannot be estimated using these methods, the pur-
pose of the study was to examine the distribution of
cloxacillin was examined in vitro after intramammary
administration using the isolated perfused bovine udder
as previously described [8,4,5].
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Test formulations
Injectors containing 600 mg cloxacillin benzathine
(formulated as Orbenin Extra Dry Cow, Pfizer Animal
Health, Sandwich, UK) wereu s e d .O r b e n i nE x t r aD r y
Cow is approved for intramammary administration to
cows at drying off.
Isolated perfused bovine udder
As described in detail by Kietzmann et al. [8], medium
sized udders with a symmetric shape and a teat length
of 6-8 cm from healthy German Black Pied cows that
were lactating prior to slaughter were used. Each cow’s
udder was examined prior to slaughter by palpation of
the quarters and inspection of the milk to check for the
absence of clinical mastitis. Within 10 - 15 min post-
slaughter, blood clots in the vessels of the glands were
cleared using 1 L heparinised Tyrode solution per udder
half. Thereafter, the udders were transported for 20 min
in a plastic tub to the laboratory. Within a few minutes
after arrival at the laboratory, the udder was fixed in a
“natural” position to a metal frame using the proximally
inserting skin and suspensory ligament. Within a few
minutes, the large arteries of the udder were supplied
with the perfusion fluid delivered via silicone tubes. The
larger veins were also cannulated to allow sampling and
removal of the perfusate, whereas the smaller veins were
closed using artery forceps. Six front and rear quarters
from six udder udders were used.
Each udder half was perfused with 90 - 120 mL/min
of Tyrode solution (136.8 mmol/L NaCl, 2.7 mmol/L
KCl, 1.8 mmol/L CaCl2 ×2 H 2O, 1.05 mmol/L MgCl2 ×
6H2O, 0.416 mmol/L NaH2PO4 ×2 H 2O, 11.9 mmol/L
NaHCO3 and 5.5 mmol/L D(+)-glucose × 1H2O; 39°C)
gassed with carbogen (95% O2,5 %C O 2)u s i n gap e r i -
staltic pump. The mammary glands were milked over
about 5 minutes during a 30 min equilibration phase.
The viability of the perfused udders was controlled
using biochemical parameters such as lactate dehydro-
genase(LDH)-activity, glucose consumption and lactate
production in the perfusate [4,5,8]. The perfusate flux
was about 90-120 mL/minute per udder half.
Study design
After reaching a physiological like status during the equi-
libration period, one intramammary syringe of Orbenin
Extra Dry Cow each was administered via the teat canal
and massaged into the glandular cistern of one front and
one rear quarter of the same side of the udder. After 6 h,
four gland tissue samples were taken from the central
region of the treated quarters (front quarter: 4, 8, 12, 16
cm distance to the teat, rear quarter: 5, 10, 15, 20 cm dis-
tance to the teat). Perfusate was sampled before and
hourly after treatment for six h. Perfusate and tissue sam-
ples were stored frozen at -20°C.
Analysis of cloxacillin concentrations
Concentrations of cloxacillin in glandular tissue and in
perfusate samples were analysed using a high perfor-
mance liquid chromatography (HPLC) method.
Tissue extraction. Samples of glandular tissue (1 g)
were spiked with 10 mL of an internal standard stock
solution [1.0 g/l oxacillin (Sigma, Deisenhofen, Ger-
many) for cloxacillin quantification and filled up to a
total volume of 4 mL with Soerensen phosphate buffer
[33 mmol/l KH2PO4/Na2HPO4 (Merck, Darmstadt, Ger-
many) at pH 6.8 for cloxacillin extraction. Soerensen
phosphate buffer was also used in all further steps of
extraction. The tissue was homogenized at 20 000 rpm
at 4°C for 90 s (Ultra Turrax®, Janke and Kunkel, Stau-
fen, Germany). After centrifugation at 23000 g at 4°C
for 5 min, a supernatant fluid free of visible particles
was obtained. For the following fluid-fluid extraction
and detection of oxacillin by high pressure liquid chro-
matography (HPLC), a method of Schadewinkel-Scherkl
[13] was modified. 1.5 mL of the prepared samples was
added with 3 mL dichloromethane (Merck, Darmstadt,
Germany) and immediately after acidifying with 100 μl
0.5 mol/l sulphuric acid was moderately shaken for 20 s.
This was followed by centrifugation at 1500 g at 4°C for
10 min. Then 2 mL of the lower organic phase was
intensively mixed with 1 mL phosphate buffer for 20 s
and centrifuged again and the supernatant was separated
for analysis.
HPLC analysis. Sub-samples of 100 μl were injected by
an autosampler (Model 508, Beckman, Fullerton, CA,
USA) and chromatographed at 40°C on a HPLC column
(LiChroCART® 250-4 mm, LiChrospher® 100 RP-18e
(5 μm), Merck, Darmstadt, Germany) combined with a
guard column (LiChroCART® 4-4 mm, LiChrospher®
100 RP-18e (5 μm), Merck, Darmstadt, Germany). The
eluent for cloxacillin analysis [phosphate buffer
(33 mmol/l KH2PO4/Na2HPO4, pH 2.6)/acetonitrile
(Roth, Karlsruhe, Germany) 66 : 34] was pumped at a
flow rate of 1.5 mL/min (Model 126, Beckman, Fuller-
ton, CA, USA). Cloxacillin was detected using ultraviolet
light (Model 166, Beckman, Fullerton, CA, USA) at a
wavelength of 210 nm. The areas under the curves were
directly integrated (Software 32 Karat 5.0, Beckman,
Fullerton, CA, USA).
Analysis validation. For the calculation of experimental
sample concentrations, untreated udder matrix was
spiked with the analyte [5 μg/g tissue]. Calibration curves
were in the range of 0.5 to 5 and 5 to 400 μg cloxacillin/
g tissue. The spiked samples were extracted and analysed
under the same conditions as the experimental samples
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for cloxacillin. The limit of quantification was 0.56 μg/g.
Intraday and interday precision were below 20%.
Results
The concentration of cloxacillin in the glandular tissue
of all front quarters measured 6 h after administration
tended to decrease with increasing vertical distance
from the teat. Figure 1 shows this on a logarithmic
scale. The decreasing pattern of the concentration could
be explained by the high variation of the measured con-
centrations in the teat region. Especially in one udder
quarter, a very high concentration of cloxacillin was
measured near the teat. Starting with 4.1 μg/g near the
teat (median), the concentration declined to 2.8, 2, 4
and 1.7 μg/g at distances of 8, 12 and 16 cm to the teat.
At the base of five udder quarters, the cloxacillin con-
centration was between 0.73 and 2.52 μg/g while the
cloxacillin was below the limit of quantification in one
udder quarter. In contrast to the front quarters, the
decrease of the concentration was not quite clear in rear
quarters (figure 2). The cloxacillin concentration was
measured between 0.67 and 4.2 μg/g in all tissue sam-
ples. Taken together, a tendency to have a quite even
good distribution trough the gland tissue was obvious.
The concentrations measured in the perfusate samples
were below the limit of quantification, which indicates
low absorption from the glandular tissue into the sys-
temic circulation.
Discussion
The isolated perfused bovine udder has already been
shown to be a suitable in vitro model for studying the
pharmacokinetics of substances administered by the
intramammary route and by simulation of the systemic
route [4,5]. There are only few published comparative
studies on the distribution of active compounds in the
udder tissue in vivo [3]. Although it is not yet clear
whether the isolated perfused bovine udder accurately
reflects the situation in vivo, studies in the isolated per-
fused bovine udder offer the possibility to obtain princi-
ple knowledge about the distribution in the gland tissue
as well as an answer to the question if sufficient antibac-
terial concentrations may be reached. It has to be con-
sidered that the study was performed using udders from
slaughtered lactating cows. Because dry off formulations
a r eu s e di nt h eb e g i n n i n go ft h ed r yo f fp e r i o d ,t h e
results reflect the physiological situation because milk
production is not declined at drying off.
Given the inherent variability of the measured concen-
tration between udders which is consistent with other
studies [3], the differences in cloxacillin concentrations
observed in this study between various locations in the
gland tissue reflect a good distribution in all regions of
Figure 1 Cloxacillin concentration (μg/g tissue) in the
glandular tissue of front quarters of the isolated perfused
bovine udder measured at constant vertical distances from the
teat base 6 h after the intramammary administration of 600
mg cloxacillin benzathine (Orbenin™ extra dry cow) per
quarter. Data are given as box plots from six single experiments.
The dotted line shows the MIC90 of 0.5 μg/mL against
Staphylococcus aureus.
Figure 2 Cloxacillin concentration (μg/g tissue) in the
glandular tissue of rear quarters of the isolated perfused
bovine udder measured at constant vertical distances from the
teat base 6 h after the intramammary administration of 600
mg cloxacillin benzathine (Orbenin™ extra dry cow) per
quarter. Data are given as box plots from six single experiments.
The dotted line shows the MIC90 of 0.5 μg/mL against
Staphylococcus aureus.
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data, individual results show that sufficient antibacterial
concentrations above an MIC of 0.5 μg/g were reached.
The good distribution is probably related to the low
particle size, afforded by the bead milling process of the
formulation (Dynomill process), which ensures homoge-
nicity of the formulation [2]. So, a concentration of
more than 0.5 μg/g was reached also in the region of
the udder base. In the present study, cloxacillin was
measurable in all tissue samples of isolated perfused
bovine udders which were treated intramammary with
cloxacillin benzathine (Orbenin Extra Dry Cow) with
the exception of one sample (front quarter at the base
of the udder).
Following the administration of any intramammary
formulation, the concentrations of drugs in the glandu-
lar tissue near the teat (cisternal area) are expected to
be higher than at the base of the udder [3]. In the pre-
sent study, this fact is confirmed in the front quarters
but not in the rear quarters. Ehinger and Kietzmann [3]
measured the cloxacillin concentration three hours after
administration, while the samples were taken after six
hours in the present study. Therefore, the trend to
decrease seems to be lower in the present study than in
the previous study where tissue samples were taken ear-
lier. Nevertheless, the cloxacillin concentration was
above 0.5 μg/g in all investigated regions of the rear
quarters of the udder tissue. For Staphylococcus aureus
and also for Streptococcus uberis cultured from cattle
with mastitis, MIC90 values of 0.5 μg/mL for cloxacillin
have been reported in a recent pan-European survey
[12,15]. It can be concluded that potential effective con-
centrations can be reached in all regions of the front
and rear quarters of the udder using the tested formula-
tion containing 600 mg cloxacillin benzathine, although
it has to be considered that additional factors may affect
the antibacterial efficacy such as protein binding, osmo-
tic pressure and inhibitory substances. The range of the
measured tissue concentrations is comparable with
results of Ehinger und Kietzmann [4,5], who studied the
tissue distribution of oxacillin after intramammary
administration of a formulation designated for use in
lactating cows.
In the present study, there was considerable variation
in the tissue concentrations of cloxacillin. This is in
line with the findings of previous studies for benzylpe-
nicillin, oxacillin, ampicillin, cefquinome and marbo-
floxacin [4-6,9]. This is probably due to an individual
variation between healthy bovine udders, such as dif-
ferences in glandular size, which also appears fre-
quently to be correlated with the volume of secretion
and enhance dilution of the active compound in the
secreted milk [3]. So, this variability could reflect a
normal situation in the field. The present study was
conducted in a relatively small number of mammary
glands (six front and rear quarters each) and therefore
no statistical analysis was possible. The number of per-
fused udders used in the present study was not
increased to allow the performance of additional statis-
tical analysis, because the variation of the data reflects
the real situation in vivo.
Sampling from different regions of the udder is very
important when assessing the pharmacokinetics of a
drug, with four locations per quarter representing the
minimum, since antibiotics distribute more unevenly in
glandular tissue [7] than is assumed based on milk ana-
lysis [3]. When measuring the drug concentration in
milk samples from treated cows, this information can
not be obtained. In contrast, the isolated perfused
bovine udder allows obtaining this information without
the ethical limitations of an in vivo study. Differences
in vehicle and especially in the particle size of the sus-
pended active principles have an influence on the dis-
tribution of antibiotics administered locally into the
bovine udder [4,5,14]. Best tissue distribution rates are
expected when the active compound is administered in
a formulation with homogeneously distributed particles
of low size, which is the case for Orbenin Extra Dry
Cow, where the low particle size is obtained by the
bead milling process of the formulation (Dynomill
process).
This is the first study that shows antibacterial concen-
trations in udder tissue after intramammary administra-
tion of a dry off product containing cloxacillin measured
six h after administration, concentrations of more than
0.5 μg/g were reached in all regions of the front and
rear quarters. Studies in the isolated perfused bovine
udder can help therefore also to screen new candidate
formulations for intramammary administration to select
those that will be suitable for testing in vivo as it was
demonstrated by Ehinger and Kietzmann [5].
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